Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan
{"title":"推进转移性癌症的精确肿瘤学：食品药品监督管理局批准基础一液体CDx作为伴随诊断对应物。","authors":"Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan","doi":"10.1177/20363613231204798","DOIUrl":null,"url":null,"abstract":"malignant","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231204798"},"PeriodicalIF":0.9000,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/b9/10.1177_20363613231204798.PMC10521303.pdf","citationCount":"0","resultStr":"{\"title\":\"Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence.\",\"authors\":\"Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan\",\"doi\":\"10.1177/20363613231204798\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"malignant\",\"PeriodicalId\":46078,\"journal\":{\"name\":\"Rare Tumors\",\"volume\":\"15 \",\"pages\":\"20363613231204798\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/b9/10.1177_20363613231204798.PMC10521303.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rare Tumors\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20363613231204798\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20363613231204798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
